Elacestrant Interactions
There are 291 drugs known to interact with elacestrant, along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 92 are major, 157 are moderate, and 42 are minor.
- View elacestrant alcohol/food interactions (1)
- View elacestrant disease interactions (1)
Medications known to interact with elacestrant
Note: Showing generic names only.
- abametapir topical
- adagrasib
- afatinib
- aldesleukin
- aliskiren
- alpelisib
- alvimopan
- ambrisentan
- aminoglutethimide
- amiodarone
- amlodipine
- amobarbital
- amprenavir
- apalutamide
- apixaban
- apremilast
- aprepitant
- armodafinil
- artesunate
- asciminib
- atazanavir
- atorvastatin
- avacopan
- belinostat
- belzutifan
- berotralstat
- betrixaban
- bexarotene
- bicalutamide
- binimetinib
- boceprevir
- bosentan
- bosutinib
- brentuximab
- brigatinib
- butabarbital
- butalbital
- cabazitaxel
- capivasertib
- carbamazepine
- cenobamate
- ceritinib
- chloramphenicol
- cimetidine
- ciprofloxacin
- cladribine
- clarithromycin
- clofazimine
- clotrimazole
- cobicistat
- cobimetinib
- colchicine
- conivaptan
- crizotinib
- cyclosporine
- dabigatran
- dabrafenib
- daclatasvir
- dactinomycin
- danazol
- daridorexant
- darolutamide
- darunavir
- dasatinib
- daunorubicin
- daunorubicin liposomal
- deferasirox
- dehydroepiandrosterone
- delafloxacin
- delavirdine
- dexamethasone
- dextromethorphan
- digoxin
- diltiazem
- docetaxel
- doxorubicin
- doxorubicin liposomal
- dronedarone
- duvelisib
- echinacea
- edoxaban
- efavirenz
- elafibranor
- elagolix
- eliglustat
- eltrombopag
- empagliflozin
- encorafenib
- entrectinib
- enzalutamide
- epirubicin
- erdafitinib
- erlotinib
- erythromycin
- eslicarbazepine
- ethinyl estradiol
- etoposide
- etravirine
- everolimus
- fedratinib
- felbamate
- fenfluramine
- fexinidazole
- fexofenadine
- fidaxomicin
- fluconazole
- fluoroestradiol F 18
- fluvoxamine
- fosamprenavir
- fosaprepitant
- fosphenytoin
- fostamatinib
- idarubicin
- idelalisib
- imatinib
- indacaterol
- indinavir
- iptacopan
- irinotecan
- irinotecan liposomal
- isavuconazonium
- isoniazid
- itraconazole
- ivacaftor
- ivermectin
- ivosidenib
- ixabepilone
- lanreotide
- lapatinib
- larotrectinib
- lazertinib
- lefamulin
- lemborexant
- lenacapavir
- lesinurad
- letermovir
- levoketoconazole
- linagliptin
- lomitapide
- lonafarnib
- lonapegsomatropin
- loperamide
- loratadine
- lorlatinib
- lurasidone
- lusutrombopag
- maraviroc
- maribavir
- mavacamten
- mavorixafor
- mephobarbital
- methadone
- methotrexate
- metreleptin
- mibefradil
- miconazole
- mifepristone
- mirabegron
- mitapivat
- mitomycin
- mitotane
- mitoxantrone
- mobocertinib
- modafinil
- morphine
- nafcillin
- naldemedine
- naloxegol
- nefazodone
- nelfinavir
- nevirapine
- nicardipine
- nifedipine
- nilotinib
- nintedanib
- niraparib
- nirogacestat
- paclitaxel
- pacritinib
- palbociclib
- pasireotide
- pazopanib
- pentobarbital
- pexidartinib
- phenobarbital
- phenylbutazone
- phenytoin
- pirtobrutinib
- pitolisant
- posaconazole
- pralsetinib
- primidone
- progesterone
- prucalopride
- ranolazine
- relugolix
- repotrectinib
- ribociclib
- rifabutin
- rifampin
- rifapentine
- rifaximin
- rimegepant
- riociguat
- ripretinib
- ritlecitinib
- ritonavir
- rivaroxaban
- romidepsin
- rosuvastatin
- rucaparib
- rufinamide
- saquinavir
- saxagliptin
- secobarbital
- seladelpar
- selexipag
- selpercatinib
- silodosin
- sirolimus
- sirolimus protein-bound
- sirolimus topical
- sitagliptin
- sofosbuvir
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotorasib
- st. john's wort
- stiripentol
- sulfasalazine
- sulfinpyrazone
- suvorexant
- suzetrigine
- tacrolimus
- talazoparib
- tazemetostat
- tecovirimat
- telaprevir
- telithromycin
- telotristat
- teniposide
- tenofovir alafenamide
- tenofovir disoproxil
- terfenadine
- teriflunomide
- ticagrelor
- tipranavir
- tolvaptan
- topotecan
- tovorafenib
- trametinib
- treosulfan
- trofinetide
- troglitazone
- troleandomycin
- tucatinib
- vadadustat
- vemurafenib
- venetoclax
- verapamil
- vibegron
- viloxazine
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- vorasidenib
- voriconazole
- voxelotor
Elacestrant alcohol/food interactions
There is 1 alcohol/food interaction with elacestrant.
Elacestrant disease interactions
There is 1 disease interaction with elacestrant which include:
Report options
More about elacestrant
- elacestrant consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: estrogen receptor antagonists
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
